EPFL
Faulty regulation of an architect gene can lead to rare bone disease
Research
EPFL
EPFL researchers found that, if expressed too early during embryonic development, one of the genes that orchestrate the formation of limbs can lead to a rare disorder of bone growth.
LiftPose3D: Turning 2D images into 3D models
Research
EPFL
EPFL scientists have developed a deep learning-based method called LiftPose3D, which can reconstruct 3D animal poses using only 2D poses from one camera. This method will have impact in neuroscience and bioinspired robotics.
Improving mobile COVID vaccination efforts through GIS mapping
Research
EPFL
EPFL has teamed up with Vaud Canton’s Office for Civil Protection and General Health Office to deploy targeted mobile COVID vaccination centers and inform high risk groups about the importance of getting vaccinated in order to stem the pandemic.
Rheon Medical is revolutionizing the surgical treatment of glaucoma
TechTransfer
EPFL
EPFL spin-off Rheon Medical has developed the world’s first adjustable glaucoma drainage system, which has already been used successfully in over 250 patients in Europe. The company, based at EPFL Innovation Park, closed a CHF 5.6 million Series C funding round in December 2020 and just received the U.S. FDA’s Breakthrough Device Designation for its technology.
Scientific reasoning requires the irrationality of intuition
Research
EPFL
EPFL Summer Series: How science works. Science is based on coherent reasoning, while intuition follows a more disjointed path. But scientific research couldn’t succeed if scientists didn’t listen to their gut feelings every once in a while.
Lung cancer: Hope for increasing immunotherapy efficacy
Research
EPFL
A “paradox and setback” forced EPFL scientists to dig deeper when seeking a means to boost the power of immunotherapy in lung cancer. Understanding the problem – and finding the solution – has led to a promising potential therapy for some patients.
Page 78 of 96